Pass HI - Search Results

1

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.

Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J, Asano H, Ueno T, Muraoka T, Yamamoto H, Nasu Y, Kishimoto T, Pass HI, Matsui H, Huh NH, Miyoshi S. Kubo T, et al. Among authors: pass hi. Clin Cancer Res. 2011 Aug 1;17(15):4965-74. doi: 10.1158/1078-0432.CCR-10-3040. Epub 2011 Jun 14. Clin Cancer Res. 2011. PMID: 21673066

2

Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma.

Pass HI. Pass HI. Chest Surg Clin N Am. 1994 Aug;4(3):497-515. Chest Surg Clin N Am. 1994. PMID: 7953481 Review.

3

Malignant pleural mesothelioma: newer aspects of carcinogenesis, molecular genetics, and prospects for future therapies.

Donington JS, Mew DJ, Pass HI. Donington JS, et al. Among authors: pass hi. Surg Oncol. 1995 Aug;4(4):175-85. doi: 10.1016/s0960-7404(10)80034-9. Surg Oncol. 1995. PMID: 8528480 Review.

4

Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.

Pass HI, Mew DJ, Carbone M, Matthews WA, Donington JS, Baserga R, Walker CL, Resnicoff M, Steinberg SM. Pass HI, et al. Cancer Res. 1996 Sep 1;56(17):4044-8. Cancer Res. 1996. PMID: 8752177

5

Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.

Ohta Y, Shridhar V, Kalemkerian GP, Bright RK, Watanabe Y, Pass HI. Ohta Y, et al. Among authors: pass hi. Cancer. 1999 Jun 15;85(12):2570-6. Cancer. 1999. PMID: 10375104

6

Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma.

Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, Gilcrease M, Farinas A, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: pass hi. Cancer Res. 2001 Aug 1;61(15):5727-30. Cancer Res. 2001. PMID: 11479207

7

Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP.

Dote H, Tsukuda K, Toyooka S, Yano M, Pass HI, Shimizu N. Dote H, et al. Among authors: pass hi. Oncol Rep. 2004 Feb;11(2):361-3. Oncol Rep. 2004. PMID: 14719068

8

Gene expression profiles predict survival and progression of pleural mesothelioma.

Pass HI, Liu Z, Wali A, Bueno R, Land S, Lott D, Siddiq F, Lonardo F, Carbone M, Draghici S. Pass HI, et al. Clin Cancer Res. 2004 Feb 1;10(3):849-59. doi: 10.1158/1078-0432.ccr-0607-3. Clin Cancer Res. 2004. PMID: 14871960

9

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.

Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF. Shivapurkar N, et al. Among authors: pass hi. Int J Cancer. 2004 May 1;109(5):786-92. doi: 10.1002/ijc.20041. Int J Cancer. 2004. PMID: 14999791

10

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies.

Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF. Shigematsu H, et al. Among authors: pass hi. Int J Cancer. 2005 Feb 10;113(4):600-4. doi: 10.1002/ijc.20622. Int J Cancer. 2005. PMID: 15472908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters